(Q37864239)

English

A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials

scientific article published on 11 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

A critical appraisal of the premotor symptoms of Parkinson's disease: potential usefulness in early diagnosis and design of neuroprotective trials (English)

1 reference

Europe PubMed Central

24 August 2017

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1

object named as

Anthony E Lang

1 reference

Europe PubMed Central

24 August 2017

language of work or name

0 references

publication date

11 April 2011

1 reference

Europe PubMed Central

24 August 2017

Movement Disorders

1 reference

Europe PubMed Central

24 August 2017

26

1 reference

Europe PubMed Central

24 August 2017

5

1 reference

Europe PubMed Central

24 August 2017

775-783

1 reference

Europe PubMed Central

24 August 2017

Overview of the extranigral aspects of Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Invited article: changing concepts in Parkinson disease: moving beyond the decade of the brain

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

A critical evaluation of the Braak staging scheme for Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Do alpha-synuclein aggregates in autonomic plexuses predate Lewy body disorders?: a cohort study.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

The efficacy of combining several risk factors as a screening test

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

When can a risk factor be used as a worthwhile screening test?

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Incidental Lewy body disease: clinical comparison to a control cohort

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Neural control of the gastrointestinal tract: implications for Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Involvement of vagal autonomic nuclei in multiple system atrophy and Lewy body disease.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Frequency of bowel movements and the future risk of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Bowel movement frequency in late-life and incidental Lewy bodies

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Medical records documentation of constipation preceding Parkinson disease: A case-control study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Bowel movement frequency in late-life and substantia nigra neuron density at death

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism-predominant multiple system atrophy.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

The olfactory system and its disorders

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Prevalence of smell loss in Parkinson's disease--a multicenter study

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography, and SPECT.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Olfactory loss and nigrostriatal dopaminergic denervation in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Enlarged hyperechogenic substantia nigra is related to motor performance and olfaction in the elderly

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Association of olfactory dysfunction with incidental Lewy bodies.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Association of olfactory dysfunction with risk for future Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Smell identification ability in twin pairs discordant for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Idiopathic hyposmia as a preclinical sign of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Excessive daytime sleepiness and subsequent development of Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Quantifying the risk of neurodegenerative disease in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

REM sleep behavior disorder preceding other aspects of synucleinopathies by up to half a century

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Relevance of substantia nigra hyperechogenicity and reduced odor identification in idiopathic REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Midbrain hyperechogenicity in idiopathic REM sleep behavior disorder

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson's disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Cardiac autonomic dysfunction in idiopathic REM sleep behavior disorder.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Severity of REM atonia loss in idiopathic REM sleep behavior disorder predicts Parkinson disease

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study [corrected].

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Substantia nigra echomorphology and motor cortex excitability.

1 reference

https://api.crossref.org/works/10.1002%2FMDS.23609

21 January 2018

Identifiers

10.1002/MDS.23609

1 reference

Europe PubMed Central

24 August 2017

1 reference

Europe PubMed Central

24 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37864239&oldid=2113561367"